Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME   >  CORPORATE INFO >  BOARD MEETINGS
Board Meetings      
Indraprastha Medical Corporation Ltd.
Source DateBoard Meeting DateDetails
21-Jan-2025 03-Feb-2025 Quarterly Results
21-Oct-2024 30-Oct-2024 Quarterly Results
24-Jul-2024 05-Aug-2024 Quarterly Results
09-May-2024 17-May-2024 Final Dividend & Audited Results
05-Mar-2024 07-Mar-2024 Inter alia, to consider and approve the appointment of an Independent Director on the Board of Directors of the Company.
29-Jan-2024 06-Feb-2024 Quarterly Results
20-Oct-2023 03-Nov-2023 Quarterly Results
25-Jul-2023 04-Aug-2023 Quarterly Results
11-May-2023 23-May-2023 Audited Results & Dividend
23-Jan-2023 08-Feb-2023 Quarterly Results
20-Oct-2022 04-Nov-2022 Quarterly Results
29-Jul-2022 08-Aug-2022 Quarterly Results
31-Jan-2022 08-Feb-2022 Quarterly Results
01-Nov-2021 09-Nov-2021 Quarterly Results
02-Aug-2021 09-Aug-2021 Quarterly Results
01-Jun-2021 09-Jun-2021 Audited Results
29-Jan-2021 08-Feb-2021 Quarterly Results
04-Nov-2020 10-Nov-2020 Quarterly Results
14-Aug-2020 24-Aug-2020 Quarterly Results
14-May-2020 23-May-2020 Audited Results
Page 1 of 5
Prev || Next
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.